HIGHLIGHTS
- who: Alessandro Passardi et al. from the Universitu00e9 catholique de Louvain, BelgiumUniversity and National Clinical Research Center for Digestive Diseases, Beijing, China, Department of have published the article: Editorial: Angiogenesis blockade for the treatment of gastrointestinal cancer, in the Journal: (JOURNAL) of 19/01/2023
- how: Showed that a greater decrease in VEGFC and Ang2 levels measured at the beginning of the third cycle of therapy compared to baseline corresponded to a lower risk of progression and therefore a longer progression-free survival. The authors declare that the research was conducted in the absence of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.